Hepatic Cell News Volume 8.04 | Feb 02 2024

    0
    6







    2024-02-02 | HCN 8.04


    Hepatic Cell News by STEMCELL Technologies
    Vol. 8.04 – 2 February, 2024
    TOP STORY

    Matrix Viscoelasticity Promotes Liver Cancer Progression in the Pre-Cirrhotic Liver

    Scientists found that, in HCC patients and animal models, advanced glycation end-products promoted changes in collagen architecture and enhanced extracellular matrix viscoelasticity, with greater viscous dissipation and faster stress relaxation, but not changes in stiffness.
    [Nature]

    Full ArticlC
    Tips to prepare for your next conference or networking event
    PUBLICATIONSRanked by the impact factor of the journal

    Antioxidative Hyaluronic Acid-Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy

    Scientists developed a strategy that combined CD44-targeting of activated hepatic stellate cells (HSCs) with an antioxidative approach. They demonstrated that intravenously administered hyaluronic acid–bilirubin nanoparticles effectively targeted the liver in fibrotic mice.
    [ACS Nano]

    AbstractGraphical Abstract

    Nuclear to Cytoplasmic Transport Is a Druggable Dependency in MYC-Driven Hepatocellular Carcinoma

    Investigators comprehensively identified genes essential for survival of MYChigh but not MYClow cells by a CRISPR/Cas9 genome-wide screen in a MYC-conditional HCC model.
    [Nature Communications]

    Full Article

    Role of UPF1 in lncRNA-HEIH Regulation for Hepatocellular Carcinoma Therapy

    Researchers revealed that UPF1 regulated the abundance of hepatocellular carcinoma and upregulated EZH2-associated lncRNA (lncRNA-HEIH) by binding the CG-rich motif, thereby regulating HCC tumorigenesis.
    [Experimental & Molecular Medicine]

    Full Article

    Hepatic Stellate Cell-Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis

    The authors developed a silica cross-linked micelles (SCLMs) based nano-system for both diagnosing and treating liver fibrosis. The SCLMs were firstly modified with peptide CTCE9908 and could actively target CXCR4, which was overexpressed in activated hepatic stellate cells.
    [Advanced Healthcare Materials]

    Abstract

    Exosome-Derived tRNA Fragments tRF-GluCTC-0005 Promotes Pancreatic Cancer Liver Metastasis by Activating Hepatic Stellate Cells

    Scientists found that pancreatic ductal adenocarcinoma cells could promote the formation of pre-metastatic niches through exosomes to facilitate liver metastasis in the early stage. Hepatic stellate cells were treated with PDAC-derived exosomes, and the activation of HSCs was detected.
    [Cell Death & Disease]

    Full ArticleGraphical Abstract

    Downregulation of Roundabout Guidance Receptor 2 Suppresses Hepatocellular Carcinoma Progression by Interacting with Y-Box Binding Protein 1

    Researchers explored the function and mechanism of Robo2 and its downstream target genes in HCC. Robo2 protein levels in human HCC tissues and paired adjacent normal liver tissues were detected.
    [Scientific Reports]

    Full Article

    G6PD and Machine Learning Algorithms As Prognostic and Diagnostic Indicators of Liver Hepatocellular Carcinoma

    Investigators conducted a comprehensive investigation into the role of G6PD in liver hepatocellular carcinoma using a combination of bioinformatics analysis with database data and rigorous cell experiments.
    [BMC Cancer]

    Full Article
    Reproducibly Culture 3D Cell Models With AggreWellâ„¢ MicroWell Plates
    REVIEWS

    Therapeutic Potential of Oleanolic Acid in Liver Diseases

    The authors explore the mechanisms of action of oleanolic acid (OA) compounds in both in vitro and in vivo research models and, ultimately, highlight OA as a promising candidate for alternative therapies in the treatment and management of chronic liver disease.
    [Naunyn-Schmiedebergs Archives Of Pharmacology]

    Abstract
    INDUSTRY AND POLICY NEWS

    1 in 10 Cases of Dementia May Be Misdiagnosed Liver Cirrhosis, Study Finds

    A new study of aging US veterans finds that one in every 10 who have been diagnosed with dementia might have brain impairments caused by liver cirrhosis. “It’s a condition called hepatic encephalopathy, and it’s often treatable”, explained Dr. Jasmohan Bajaj, of the the Richmond VA Medical Center in Virginia.
    [United Press International]

    Press Release
    FEATURED EVENT

    EASL Liver Cancer Summit 2024

    February 22 – 24, 2024
    Rotterdam, Netherlands

    > See All Events

    JOB OPPORTUNITIES

    PhD Fellow – Viral Hepatitis and Disease Modelling

    University of Antwerp – Antwerp, Belgium

    Research Fellow – Achieving Functional Cure of Chronic Hepatitis B

    National University of Singapore – Singapore, Singapore

    Research Fellow – iPSCs and/or Hepatobiology

    National University of Singapore – Singapore, Singapore

    Postdoctoral Researchers – Advanced Imaging & 3D Genome Analysis in Cancer Biology

    Karolinska Institutet – Solna, Sweden

    Research Fellow – Structural Biology of RNA

    University of Birmingham – Birmingham, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2